Kancera: Positive phase Ib results in KANDOVA - Redeye
Redeye leaves a short comment following Kancera's announcement from earlier this morning regarding clinical advancements in the KANDOVA study with candidate KAND567.
ANNONS
Redeye leaves a short comment following Kancera's announcement from earlier this morning regarding clinical advancements in the KANDOVA study with candidate KAND567.